These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29290796)

  • 1. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.
    Li L; Xie H; Liang L; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C
    Carcinogenesis; 2013 Feb; 34(2):257-67. PubMed ID: 23104178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cafestol inhibits colon cancer cell proliferation and tumor growth in xenograft mice by activating LKB1/AMPK/ULK1-dependent autophagy.
    Feng Y; Yang J; Wang Y; Wang X; Ma Q; Li Y; Zhang X; Wang S; Zhang Q; Mi F; Wang Y; Zhong D; Yin J
    J Nutr Biochem; 2024 Jul; 129():109623. PubMed ID: 38492819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
    Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
    J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.
    Liu W; Wang X; Liu Z; Wang Y; Yin B; Yu P; Duan X; Liao Z; Chen Y; Liu C; Li X; Dai Y; Tao Z
    Br J Cancer; 2017 Oct; 117(8):1139-1153. PubMed ID: 29017179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo.
    Kobayashi T; Inoue T; Shimizu Y; Terada N; Maeno A; Kajita Y; Yamasaki T; Kamba T; Toda Y; Mikami Y; Yamada T; Kamoto T; Ogawa O; Nakamura E
    Mol Endocrinol; 2010 Apr; 24(4):722-34. PubMed ID: 20203103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.
    Zhang P; Liu X; Li H; Chen Z; Yao X; Jin J; Ma X
    Sci Rep; 2017 Jun; 7(1):3158. PubMed ID: 28600513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
    Li N; Wang Y; Neri S; Zhen Y; Fong LWR; Qiao Y; Li X; Chen Z; Stephan C; Deng W; Ye R; Jiang W; Zhang S; Yu Y; Hung MC; Chen J; Lin SH
    Nat Commun; 2019 Sep; 10(1):4363. PubMed ID: 31554794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.
    Chen Y; Gera L; Zhang S; Li X; Yang Y; Mamouni K; Wu AY; Liu H; Kucuk O; Wu D
    Cancer Lett; 2019 Apr; 446():62-72. PubMed ID: 30660650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
    Gjyrezi A; Xie F; Voznesensky O; Khanna P; Calagua C; Bai Y; Kung J; Wu J; Corey E; Montgomery B; Mace S; Gianolio DA; Bubley GJ; Balk SP; Giannakakou P; Bhatt RS
    J Clin Invest; 2020 Jun; 130(6):3287-3298. PubMed ID: 32478682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells.
    Pu YS; Huang CY; Wu HL; Wu JH; Su YF; Yu CR; Lu CY; Wu WJ; Huang SP; Huang YT; Hour TC
    Kaohsiung J Med Sci; 2024 Jan; 40(1):23-34. PubMed ID: 37916740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
    Pencik J; Philippe C; Schlederer M; Atas E; Pecoraro M; Grund-Gröschke S; Li WJ; Tracz A; Heidegger I; Lagger S; Trachtová K; Oberhuber M; Heitzer E; Aksoy O; Neubauer HA; Wingelhofer B; Orlova A; Witzeneder N; Dillinger T; Redl E; Greiner G; D'Andrea D; Östman JR; Tangermann S; Hermanova I; Schäfer G; Sternberg F; Pohl EE; Sternberg C; Varady A; Horvath J; Stoiber D; Malcolm TI; Turner SD; Parkes EE; Hantusch B; Egger G; Rose-John S; Poli V; Jain S; Armstrong CWD; Hoermann G; Goffin V; Aberger F; Moriggl R; Carracedo A; McKinney C; Kennedy RD; Klocker H; Speicher MR; Tang DG; Moazzami AA; Heery DM; Hacker M; Kenner L
    Mol Cancer; 2023 Aug; 22(1):133. PubMed ID: 37573301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer.
    Wang Y; Xu L; Shi S; Wu S; Meng R; Chen H; Jiang Z
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells.
    Nalairndran G; Chung I; Abdul Razack AH; Chung FF; Hii LW; Lim WM; Looi CK; Mai CW; Leong CO
    J Cell Mol Med; 2021 Sep; 25(17):8187-8200. PubMed ID: 34322995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
    Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival.
    Nalairndran G; Hassan Abdul Razack A; Mai CW; Fei-Lei Chung F; Chan KK; Hii LW; Lim WM; Chung I; Leong CO
    J Cell Mol Med; 2020 Oct; 24(20):12188-12198. PubMed ID: 32926495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK potentiation by LKB1 isoforms.
    Thibert C; Perret C; Billaud M
    Oncotarget; 2015 Nov; 6(34):35139-40. PubMed ID: 26486087
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracellular Vesicle-Mediated Reversal of Paclitaxel Resistance in Prostate Cancer.
    Wang JQ; DeChalus A; Chatterjee DN; Keller ET; Mizokami A; Camussi G; Mendelsohn AR; Renzulli Ii JF; Quesenberry PJ; Chatterjee D
    Crit Rev Oncog; 2015; 20(5-6):407-17. PubMed ID: 27279238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
    Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
    J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer.
    Beier AK; Ebersbach C; Siciliano T; Scholze J; Hofmann J; Hönscheid P; Baretton GB; Woods K; Guezguez B; Dubrovska A; Markowitsch SD; Thomas C; Puhr M; Erb HHH
    Oncogene; 2024 Jun; 43(26):2038-2050. PubMed ID: 38750263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.